162 related articles for article (PubMed ID: 30980513)
1. Knockdown of lncRNA MNX1-AS1 suppresses cell proliferation, migration, and invasion in prostate cancer.
Li Z; Wang F; Zhang S
FEBS Open Bio; 2019 May; 9(5):851-858. PubMed ID: 30980513
[TBL] [Abstract][Full Text] [Related]
2. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
3. lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443.
Gao Y; Xu Y; Wang J; Yang X; Wen L; Feng J
Oncol Res; 2019 Feb; 27(3):341-347. PubMed ID: 29678219
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
Lv Y; Li H; Li F; Liu P; Zhao X
Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
Shen Y; Lv M; Fang Y; Lu J; Wu Y
J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MNX1-AS1: A novel oncogenic propellant in cancers.
Li T; Zhou S; Yang Y; Xu Y; Gong X; Cheng Y; Wang Y
Biomed Pharmacother; 2022 May; 149():112801. PubMed ID: 35290890
[TBL] [Abstract][Full Text] [Related]
8. Activation of MYO1G by lncRNA MNX1-AS1 Drives the Progression in Lung Cancer.
Lv D; Wang Y; Li S; Shao X; Jin Q
Mol Biotechnol; 2023 Jan; 65(1):72-83. PubMed ID: 35819746
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer.
Liu S; Li H; Zhu Y; Ma X; Shao Z; Yang Z; Cai C; Wu Z; Li M; Gong W; Wu X
Cancer Lett; 2022 Oct; 547():215862. PubMed ID: 35953000
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
[TBL] [Abstract][Full Text] [Related]
12. E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma.
Ye Y; Gu B; Wang Y; Shen S; Huang W
J Cell Biochem; 2019 Apr; 120(4):6145-6153. PubMed ID: 30362161
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A.
Ma JX; Yang YL; He XY; Pan XM; Wang Z; Qian YW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4756-4762. PubMed ID: 31210302
[TBL] [Abstract][Full Text] [Related]
14. MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc-Mediated Cell-Cycle Progression and Proliferation in Lung Cancer.
Zhu Q; Zhang C; Qu T; Lu X; He X; Li W; Yin D; Han L; Guo R; Zhang E
Cancer Res; 2022 Dec; 82(23):4340-4358. PubMed ID: 36214649
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
Ji D; Wang Y; Sun B; Yang J; Luo X
Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
[TBL] [Abstract][Full Text] [Related]
16. MYC-Activated LncRNA
Wu QN; Luo XJ; Liu J; Lu YX; Wang Y; Qi J; Liu ZX; Huang QT; Liu ZK; Lu JB; Jin Y; Pu HY; Hu PS; Zheng JB; Zeng ZL; Ju HQ; Xie D; Zhao Q; Xu R
Cancer Res; 2021 May; 81(10):2636-2650. PubMed ID: 33782099
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
18. LncRNA MNX1-AS1 drives aggressive laryngeal squamous cell carcinoma progression and serves as a ceRNA to target FoxM1 by sponging microRNA-370.
Cui X; Yu H; Yu T; Xiao D; Wang X
Aging (Albany NY); 2021 Mar; 13(7):9900-9910. PubMed ID: 33882027
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
20. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
